title: Oral erythromycin is ineffective in the treatment of pityriasis rosea.
abstract: BACKGROUND
  Despite the availability of various medical treatments for pityriasis rosea, a large percentage of patients fail to achieve satisfactory results. Erythromycin is reported to be effective in the treatment of pityriasis rosea.
  
  
  METHODS
  We designed a placebo-controlled study on 184 patients with pityriasis rosea attending the outpatient dermatology department at Hazrat-e-Rasul Hospital in Tehran, Iran. Adult patients were treated with 200 mg of erythromycin 4 times daily and children were treated with 20 to 40 mg/kg daily in 4 divided doses. Controls were given a placebo (an emollient cream) that was not identical in appearance. Subjects were seen at follow-up visits 2, 4, 6, and 8 weeks after starting treatment.
  
  
  RESULTS
  Both groups were comparable with regard to sex, age, and mean duration of disease at the time of attending the clinic. We found no significant difference between the 2 treatment groups at weeks 4, 6, and 8 after beginning of treatment. (p > .05 Chi2).
authors.affiliation: Department of Dermatology, Hazrat-e-Rasul Hospital, Iran University of Medical Sciences, Tehran, Iran. dr_rasi2002@yahoo.com
authors.forename: Abbas
authors.initials: A
authors.lastname: Rasi
authors.forename: Leila
authors.initials: L
authors.lastname: Tajziehchi
authors.forename: Said
authors.initials: S
authors.lastname: Savabi-Nasab
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010045:Outpatients; D017515:Pityriasis Rosea / Q000188:drug therapy*; D012737:Sex Factors; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013696:Temperature; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin